Acta Chir Orthop Traumatol Cech. 2023; 90(3):181-187 | DOI: 10.55095/achot2023/025

Popliteal Fossa SarcomasOriginal papers

O. ERDOGAN1,*, A. ÇELİK2, A. N. T. YILDIRIM3, E. TEKÇE4, G. ALTUN5, S. DEMİRÖZ6, Y. GÜLER8, K. OZKAN2, V. GURKAN7
1 Haydarpasa Numune Training and Research Hospital, Orthopaedics and Traumatology Clinic, Istanbul, Turkey
2 Istanbul Medeniyet University, Faculty of Medicine, Orthopaedics and Traumatology Clinic, Istanbul, Turkey
3 Istanbul Medeniyet University, Faculty of Medicine, Pathology Clinic, Istanbul, Turkey
4 Bezmialem University, Faculty of Medicine, Radiation Oncology Clinic, Istanbul, Turkey
5 Ümraniye Training and Research Hospital, Orthopaedics and Traumatology Clinic, Istanbul, Turkey
6 Kocaeli University, Orthopaedics and Traumatology Clinic, Kocaeli, Turkey
7 Bezmialem University, Faculty of Medicine, Orthopaedics and Traumatology Clinic, Istanbul, Turkey
8 Baltalimanı Training and Research Hospital, Orthopaedics and Traumatology Clinic, Istanbul, Turkey

PURPOSE OF THE STUDY:
Soft tissue sarcomas of the popliteal fossa are extremely rare tumors of mesenchymal origin accounting for 3%-5% of all extremity sarcomas. However, data regarding the tumor type, neurovascular involvement, and administration of radiation therapy before or after resection are limited. This study aimed to report on popliteal fossa sarcomas analyzing data from two institutions based on a relatively large patient sample.

MATERIAL AND METHODS:
Twenty-four patients (80%; 9 men and 15 women) with a popliteal fossa soft tissue sarcoma were included in this study. The reviewed patient data included sex, age, duration of complaints, interval to diagnosis, radiology, pre- and postoperative biopsy, tumor histology, surgery type, complications, and pre- and postoperative oncologic and functional outcomes. The minimum follow-up was 24 months.

RESULTS:
The mean age of the patients was 48 ± 21.23 (range 3-72) years at the time of diagnosis. The mean follow-up was 41.79 ± 16.97 (range 24-120) months. The most common histological diagnoses were synovial sarcoma (6 patients), hemangiopericytoma (2 patients), soft tissue osteosarcoma (2 patients), unidentified fusiform cell sarcoma (2 patients), and myxofibrosarcoma (2 patients). Local recurrence after limb salvage was observed in six patients (26%). At the latest follow-up, 2 patients died of the disease, 2 patients were still alive with progressive lung disease and soft tissue metastasis, and the remaining 20 patients were free from the disease.

CONCLUSIONS:
Microscopically positive margins may not be an absolute indication for amputation. Also, negative margins do not provide a guarantee that local recurrence will not occur. Lymph node or distant metastasis may be predictive factors for local recurrence rather than positive margins.

Keywords: fossa poplitea, sarcoma

Published: June 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
ERDOGAN O, ÇELİK A, YILDIRIM ANT, TEKÇE E, ALTUN G, DEMİRÖZ S, et al.. Popliteal Fossa Sarcomas. Acta Chir Orthop Traumatol Cech. 2023;90(3):181-187. doi: 10.55095/achot2023/025. PubMed PMID: 37395425.
Download citation

References

  1. Avraham T, Yan A, Zampell JC, Daluvoy SV, Haimovitz-Friedman A, Cordeiro AP, Mehrara BJ. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol. 2010;299:C589-605. Go to original source... Go to PubMed...
  2. Bell RS, O'Sullivan B, Liu FF, Powell J, Langer F, Fornasier VL, Cummings B, Miceli PN, Hawkins N, Quirt I. The surgical margin in soft tissue sarcoma. J Bone Joint Surg Am. 1989;71:370-375. Go to original source... Go to PubMed...
  3. Cantin J, McNerr GP, Chu FC, Booher RJ. The problem of local recurrence after treatment of soft tissue sarcoma. Ann Surg. 1968;168:47-53. Go to original source...
  4. Cormier JN, Ballo MT. The influence of anatomic location on functional outcome in lower-extremity soft-tissue sarcoma (comment). Ann Surg Oncol. 2004;11:453-454. Go to original source...
  5. Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, Goddard K, Freeman C, Sadura A, Zee B, Day A, Tu D, Pater J; Canadian Sarcoma Group; NCI Canada Clinical Trial Group Randomized Trial. Late radiation morbidity following randomization to preoperarive versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48-53. Go to original source...
  6. Eilber FC, Eckardt JJ, Rosen G, Nelson SD, Selch M, Eilber FR. Large, deep, high-grade extremity sarcomas: treating tumors of the flexor fossae. Surg Oncol. 1999;8:211-214. Go to original source...
  7. Eilber FR, Eckardt JJ, Rosen G, Fu YS, Seeger LL, Selch MT. Neoadjuvant chemotherapy and radiotherapy in the multidisciplinary management of soft-tissue sarcomas of the extremity. Surg Oncol Clin North Am. 1993;2:611-620. Go to original source...
  8. Enneking WF. A system of grading musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;204:9-24. Go to original source...
  9. Hohenberger P, Wysocki WM. Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose? Oncologist. 2008;13:175-186. Go to original source... Go to PubMed...
  10. Lesenskı J, Voèka M, ©paèek M, Hósová M. [Neoadjuvant use of isolated limb perfusion in large myxoid liposarcoma of the thigh: a case report]. Acta Chir Orthop Traumatol Cech. 2021;88:321-324. Go to original source... Go to PubMed...
  11. O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235-2241. Go to original source...
  12. Pritsch T, Bickels J, Winberg T, Malawer MM. Popliteal sarcomas. Presentation, prognosis, and limb salvage. Clin Orthop Relat Res. 2006;455:225-233. Go to original source...
  13. Rüdiger HA, Beltrami G, Campanacci DA, Mela MM, Franchi A, Capanna R. Soft tissue sarcomas of the popliteal fossa: outcome and risk factors. Eur J Surg Oncol. 2007;33:512-517. Go to original source...
  14. Shiu MH, Collin C, Hilaris BS, Nori D, Manolatos S, Anderson LL, Hajdu SI, Lane JM, Hopfan S, Brennan MF. Limb preservation and tumor control in the treatment of popliteal and antecubital soft tissue sarcomas. Cancer. 1986;57:1632-1639. Go to original source...
  15. Stinson SF, DeLaney TF, Greenberg J, Yang JC, Lampert MH, Hicks JE, Venzon D, White DE, Rosenberg SA, Glatstein EJ. Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1991;21:1493-1499. Go to original source...
  16. Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141:1985-1994. Go to original source...
  17. Turcotte RE, Ferrone M, Isler MH, Wong C. Outcomes in patients with popliteal sarcomas. Can J Surg. 2009;52:51-55.
  18. Wilson AN, Davis A, Bell RS, O'Sullivan B, Catton C, Madadi F, Kandel R, Fornasier VL. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994;30A:746-751. Go to original source...